Expanding Role of Pharmacogenomics in the Management of Cardiovascular Disorders
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expanding Role of Pharmacogenomics in the Management of Cardiovascular Disorders
Authors
Keywords
Warfarin, Percutaneous Coronary Intervention, Clopidogrel, Statin Therapy, Dabigatran
Journal
American Journal of Cardiovascular Drugs
Volume 13, Issue 3, Pages 151-162
Publisher
Springer Nature
Online
2013-04-11
DOI
10.1007/s40256-013-0024-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) James V. Freeman et al. ANNALS OF INTERNAL MEDICINE
- Dabigatran: Uncharted Waters and Potential Harms
- (2013) Ryan P. Radecki ANNALS OF INTERNAL MEDICINE
- Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
- (2012) Soyon Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
- (2012) Soyon Lee et al.
- Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
- (2012) Anuraag R Kansal et al. HEART
- Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
- (2012) Jason D Roberts et al. LANCET
- Is Dabigatran Cost Effective Compared With Warfarin for Stroke Prevention in Atrial Fibrillation?
- (2012) Amelia K. Adcock et al. NEUROLOGIST
- Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España
- (2012) José R. González-Juanatey et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
- (2012) Hooman Kamel et al. STROKE
- Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark
- (2012) Lars K Langkilde et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
- (2011) Shimoli V. Shah et al. CIRCULATION
- Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
- (2011) Jeffrey J.W. Verschuren et al. EUROPEAN HEART JOURNAL
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anticoagulant Options — Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran
- (2011) B. Nhi Beasley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
- (2011) Anuraag Kansal et al. THROMBOSIS AND HAEMOSTASIS
- Influence of CYP4F2 genotype on warfarin dose requirement–a systematic review and meta-analysis
- (2011) Ruijuan Liang et al. THROMBOSIS RESEARCH
- Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events
- (2010) Klaus A. Tiroch et al. AMERICAN HEART JOURNAL
- Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
- (2010) N. A. Limdi et al. BLOOD
- Heart Disease and Stroke Statistics—2011 Update
- (2010) Véronique L. Roger et al. CIRCULATION
- Acceptance of Biomarker-Based Tests for Application in Clinical Practice: Criteria and Obstacles
- (2010) M Pirmohamed CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
- (2010) Jasper Jan Brugts et al. EUROPEAN HEART JOURNAL
- Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese
- (2010) P.-C. Cha et al. HUMAN MOLECULAR GENETICS
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant
- (2010) Valentin Fuster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Haplotypes of the adrenergic system predict the blood pressure response to β-blockers in women with essential hypertension
- (2010) Fabiana Filigheddu et al. PHARMACOGENOMICS
- Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
- (2010) Mathew J. Barber et al. PLoS One
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer
- (2009) Patrick Gladding et al. JACC-Cardiovascular Interventions
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
- (2009) Nagy A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients
- (2009) Sheng-Wen Huang et al. Pharmacogenetics and Genomics
- APOE gene polymorphisms and response to statin therapy
- (2009) E Zintzaras et al. PHARMACOGENOMICS JOURNAL
- Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement— A systematic review and meta analysis
- (2009) Limei Yang et al. THROMBOSIS RESEARCH
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
- (2008) G. M. Cooper et al. BLOOD
- Pharmacogenetics of aspirin resistance: a comprehensive systematic review
- (2008) Timothy Goodman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
- (2008) MA Pacanowski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of the CYP2D6 Genotype on the Clinical Effects of Metoprolol: A Prospective Longitudinal Study
- (2008) T Rau et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine
- (2008) DM Roden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction
- (2008) J. J. Regieli et al. EUROPEAN HEART JOURNAL
- Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
- (2008) Jonatan D. Lindh et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction
- (2008) Ksenia Goryachkina et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Role of β adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis
- (2008) Amal Muthumala et al. EUROPEAN JOURNAL OF HEART FAILURE
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study
- (2008) Louise A. Donnelly et al. Pharmacogenetics and Genomics
- Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
- (2008) Tuomo Nieminen et al. PHARMACOGENOMICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started